Yahoo Finance

Selux Diagnostics Receives FDA Clearance on Their Gram-Negative Panel, Expanding the Antibiotic Menu for Its Next Generation Phenotyping System for Rapid AST

Approval gives way to the most comprehensive single menu offered by an AST platform while delivering precise, rapid results in 5.5 hours from isolated colonies. BOSTON, MA / ACCESSWIRE / April 24, ...
Monthly Prescribing Reference

FDA: New Tool to Help Clinicians Make Appropriate Antibiotic Choices

FDA LOGO BLUE New website streamlines how FDA updates information used to help health care providers choose an appropriate treatment for a patient's infection. As part of the 21st Century Cures Act, ...
The American Journal of Managed Care

FDA Releases Tool to Help Providers Make Better Prescribing Decisions for Antibiotics, Antifungals

The FDA announced a website tool aimed at healthcare providers to help them make more educated prescribing decisions about antibiotics in an effort to prevent the spread of resistant bacteria. The FDA ...
Nature

Analysis of deletion breakpoints from 1,092 humans reveals details of mutation mechanisms

Investigating genomic structural variants at basepair resolution is crucial for understanding their formation mechanisms. We identify and analyse 8,943 deletion breakpoints in 1,092 samples from the ...
Business Wire

CLSI's Publishes Annually Updated AST Supplement M100 with Standards M02 and M07

WAYNE, Pa.--(BUSINESS WIRE)--The Clinical and Laboratory Standards Institute announces the publication of its annually updated antimicrobial susceptibility testing (AST) supplement M100—Performance ...
PharmiWeb

Selux Diagnostics Receives FDA Clearance on Their Gram-Negative Panel, Expanding the Antibiotic Menu for Its Next Generation Phenotyping System for Rapid AST

Boston, Mass, April 24, 2023 (Newswire.com) - Selux Diagnostics, a biotech startup in Boston whose mission is to combat superbug infections and antimicrobial resistance (AMR), announced it has ...